Moneycontrol
Get App
Last Updated : Apr 16, 2019 03:32 PM IST | Source: PTI

Lupin gets USFDA nod to market generic depression drug

The company has received approval from the US Food and Drug Administration to market its product which is a generic version of Eli Lilly and Company's Prozac tablets.

Drug maker Lupin on April 16 said it has received approval from the US health regulator to market Fluoxetine Tablets, used to treat major depressive disorder, in the American market.

The company has received approval from the US Food and Drug Administration(USFDA) to market its product which is a generic version of Eli Lilly and Company's Prozac tablets, Lupin said in a statement.

The product is also indicated for treatment of obsessive compulsive disorder, Bulimia Nervosa and panic disorder, it said.

Shares of Lupin were trading up 0.23 percent at Rs 832.10 apiece on the BSE.
First Published on Apr 16, 2019 03:22 pm
More From
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant